Patterns of Clinical Trial Enrollment for Pediatric Patients With Hepatoblastoma and Wilms Tumor: A Report From the Children's Oncology Group

ABSTRACT Background Published childhood cancer studies have observed differences in therapeutic trial enrollment by race, ethnicity, socioeconomic status (SES), and age at diagnosis. Our study investigates patterns of enrollment for pediatric oncology clinical trials. Methods We analyzed differences...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer medicine (Malden, MA) Ročník 14; číslo 7; s. e70692 - n/a
Hlavní autoři: Monterroso, Pablo S., Lucht, Sarah, Sample, Jeannette M., Trobaugh‐Lotrario, Angela D., Parsons, Helen M., Turcotte, Lucie M., Van Riper, David, Poynter, Jenny N., Marcotte, Erin L.
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States John Wiley & Sons, Inc 01.04.2025
Wiley
Témata:
Acuity
Adolescent
Age
Cancer
Cancer research
Censuses
Child
Child, Preschool
Childhood
childhood cancer
Children
Children & youth
Clinical trials
Clinical Trials as Topic - statistics & numerical data
Decision making
Demographics
Diagnosis
Enrollments
Estimates
Ethnicity
Female
Hepatoblastoma - epidemiology
Hepatoblastoma - therapy
Hispanic Americans
Humans
Infant
Infant, Newborn
Kidney Neoplasms - therapy
Liver Neoplasms - therapy
Male
Medical research
Minority & ethnic groups
Oncology
Participation
Patient Selection
Patients
pediatric
Pediatrics
race and ethnicity
Risk assessment
Risk groups
socioeconomic status
Statistical analysis
Tumors
Wilms Tumor - epidemiology
Wilms Tumor - therapy
Canada
United States > US
childhood cancer
clinical trials
socioeconomic status
race and ethnicity
pediatric
ISSN:2045-7634, 2045-7634
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:ABSTRACT Background Published childhood cancer studies have observed differences in therapeutic trial enrollment by race, ethnicity, socioeconomic status (SES), and age at diagnosis. Our study investigates patterns of enrollment for pediatric oncology clinical trials. Methods We analyzed differences in Children's Oncology Group clinical trial enrollment in a cohort of pediatric patients with hepatoblastoma (n = 212) and Wilms tumor (n = 1107). Relative risks (RRs) and 95% confidence intervals (95% CIs) were estimated for trial enrollment by patient characteristics. Odds ratios (ORs) and 95% CIs were estimated to examine associations between characteristics and three outcomes (therapeutic trial [referent], exclusively non‐therapeutic study, no trial or study). Statistical significance tests were two‐sided. Results Approximately half of all cases enrolled in therapeutic trials for both tumor types (Wilms: 48%; hepatoblastoma: 51%). For Wilms tumor, patients diagnosed at ages 3–5 years were more likely to enroll compared to those diagnosed at age < 1 year (RR = 1.06; 95% CI = 1.01, 1.13) and had lower odds of joining exclusively a non‐therapeutic study compared to those diagnosed at age < 1 years (OR = 0.63; 95% CI = 0.44, 0.90). There was no association between race, ethnicity, or SES and enrollment. For hepatoblastoma, no variables indicated any statistically significant difference in enrollment. Conclusions Few differences in clinical trial enrollment were observed during periods when trials were available for all risk groups, a promising sign of equity in pediatric oncology clinical trial recruitment. Among Wilms tumor cases, differences in enrollment were observed for age at diagnosis, a potential proxy for disease acuity, which may influence decision making. Our study examines disparities in enrollment for pediatric oncology clinical trials, focusing on pediatric patients with hepatoblastoma and Wilms tumor. We found few disparities in trial enrollment, though young age at diagnosis was a statistically significant predictor for Wilms tumor cases.
Bibliografie:This work was supported by the National Cancer Institute (R01CA266105 to ELM), the Children's Cancer Research Fund, and grants U10CA180886, U10CA180899, U10CA098543, and U10CA098413.
Funding
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:2045-7634
2045-7634
DOI:10.1002/cam4.70692